PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

LOS ANGELES CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001177206)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,727 Value ($000) $368 Avg Close $81.85 Range $62.24 - $96.54
Q4 2024
Shares 31,366 Value ($000) $1,211 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 22,446 Value ($000) $1,010 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 30,827 Value ($000) $1,068 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 30,827 Value ($000) $892 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 9,154 Value ($000) $210 Avg Close $17.50 Range $13.72 - $23.88
Q2 2023
Shares 9,366 Value ($000) $259 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 45,473 Value ($000) $1,046 Avg Close $16.79 Range $10.62 - $25.69
Q4 2022
Shares 76,990 Value ($000) $840 Avg Close $8.44 Range $7.24 - $11.46
Q3 2022
Shares 76,990 Value ($000) $649 Avg Close $9.46 Range $7.68 - $11.97
Q2 2022
Shares 70,930 Value ($000) $561 Avg Close $12.09 Range $6.91 - $25.76
Q1 2021
Shares 47,387 Value ($000) $1,227 Avg Close $25.31 Range $18.82 - $32.10
Q4 2020
Shares 48,007 Value ($000) $968 Avg Close $21.52 Range $17.44 - $25.65
Q3 2020
Shares 46,707 Value ($000) $913 Avg Close $18.76 Range $14.16 - $23.25
Q2 2020
Shares 46,707 Value ($000) $825 Avg Close $12.55 Range $6.00 - $19.67
Q1 2020
Shares 29,117 Value ($000) $206 Avg Close $7.49 Range $5.30 - $9.30